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NOD2 signaling inhibits NF-κB signaling
Tomohiro Watanabe and colleagues show that activation of nucleotide-binding oligomerization domain 2 (NOD2) results in increased expression of interferon regulatory factor 4 and binding to tumor necrosis factor receptor-associated factor 6 (TRAF6) and receptor interacting serine-threonine kinase (RICK), resulting in inhibition of Lys63-linked polyubiquitination of TRAF6 and RICK and thus to downregulation of nuclear factor-κB (NF-κB) activation. See page 1312 
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DCs and lung injury in the elderly
Sangeetha Prakash and co-workers observed that monocyte-derived dendritic cells (DCs) from elderly, but not young, subjects produced tumor necrosis factor-α that was able to induce cytokines and chemokines and alter the barrier function of primary bronchial epithelial cells. See page 1386 
T-cell IL-4 drives Th2 cells in food allergy
SIRT1 in control of colitis
Roberta Caruso and colleagues combined analyses of human inflammatory bowel disease and mouse models to identify a role for SIRT1, an NAD-dependent deacetylase, in the control of intestinal inflammation.
See page 1467
Caspase-11 protects against DSS colitis Dieter Demon and co-workers demonstrate that caspase-11 is expressed in the colonic mucosa and protects against dextran sodium sulfateinduced (DSS) colitis, through a mechanism that is independent of inflammasome activation of interleukin-1β and -18. 
